MCAULAY CAMERON (Chief Financial Officer) reported 1 transaction at TRANSPHORM, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/5/2023ACC: 0001209191-23-040998
Officer· Chief Financial Officer
Since Feb 2020
-8.61K
Net shares
Net seller
$29.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
8.61K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.61K
Price / share
$3.40
Trade value
$29.26K
% of position
9.5%
7/1/2023
90.21K→81.60K
Total
Net shares
−8.61K
Net value
-$29.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2023 | F · Tax Withholding | −8.61K | $3.40 | $29.26K | 9.5% | 90.21K | 81.60K |
| Total | −8.61K | -$29.26K | ||||||
Derivative Transactions0
No derivative transactions reported